Clinical Trial Update: Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effect of adalimumab on vascular inflammation in adults with moderate-to-severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Psoriasis, Vascular Inflammation | Phase 4 | Status: COMPLETED